Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes

Use of high-dose, post-transplant cyclophosphamide (PTCy) results in low rates of graft-versus-host-disease (GVHD) and favorable immune reconstitution, although with higher rates of relapse and somewhat high rates of graft failure. We hypothesized that permissible dose reduction of PTCy might be fea...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncoimmunology
Prif Awduron: Wang, Yu, Chang, Ying-Jun, Chen, Lu, Xu, Lan-Ping, Bian, Zhi-Lei, Zhang, Xiao-Hui, Yan, Chen-Hua, Liu, Kai-Yan, Huang, Xiao-Jun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2017
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674947/
https://ncbi.nlm.nih.gov/pubmed/29147612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1356152
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg